Clinical Evaluation of the RAVI-Guide
Completed
Conditions studied: Retinal Diseases
In brief
Hypothesis: The RAVI-Guide provides superior patient acceptability to the conventional lid speculum during intravitreal injections Aims: To compare patient acceptance and procedural complication rates of the RAVI-Guide with those of the conventional lid speculum and caliper approach
Key facts
- Study ID
- NCT02196584
- Run by
- Medical College of Wisconsin
- People needed
- 55
- Starts
- 2014-08-01
- Expected to finish
- 2016-06-01
- Last updated by the study team
- 2016-06-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients age 18 years or older who undergo intravitreal injection for clinical indications.
You may not qualify if…
- Patients under the age of 18 years
- Patients unable to give informed consent
- Disorders that preclude the ability to judge pain or discomfort associated with intravitreal injection
- Disorders that preclude the ability to assess for complications of intravitreal injection
- Inability to assess the landmarks by which localization of intravitreal injection sites is determined, such as obscured corneal limbus
- Inability to communicate directly to the physician and immediately after the procedure the level of pain or discomfort
Where it is running
- Froedtert and Medical College of Wisconsin Eye Institute — Milwaukee, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.